Taken together, these findings highlight a molecular pathway in which PKM2 governs gliomagenesis by regulating stemness via Oct4, underlining the therapeutic potential of targeting PKM2 to disrupt cancer cell metabolism and tumor growth [89,90]. The gene discussed is PKM; the disease is neoplasm.